The history of the erectile dysfunction drug presents a intricate picture for those considering investment. While the initial release generated significant returns, the expiration of its intellectual property protection opened the door to cheaper competitors, dramatically diminishing revenue. This presents a unique risk for drug manufacturers depen

The history of Viagra, and its developer copyright, presents a complex case study for investors. Initially a blockbuster drug, generating billions in income, its intellectual property lapse created a flood of generic competition , significantly impacting its market share . While certain firms may try to capitalize on similar conditions , the curren